Correlia Biosystems

Developer of a streamlined assay platform designed to reduce the time and cost of quantifying proteins for proteomics and pharmaceutical applications. The company’s platform provides multiplexing capabilities for large protein panels including cytokines and post-translational modifications with unparalleled speed and automation, enabling researchers to obtain large panel protein studies as well as reducing the cost and time to market for candidate drug compounds.